2639-9431

Precision Nanomedicine

Andover House Inc

View prefix report (10.33218)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Deposit reference lists for 136 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact136 DOIs
2

Attach ORCID iDs across 40 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact40 DOIs
3

Add abstracts to 22 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact22 DOIs

DOIs for this ISSN

Showing the top 5 of 160 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Thymoquinone: shield and sword against SARS-CoV-2 (10.33218/001c.12984)
Abstract References ORCID License
90.31 7
2 Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior… (10.33218/prnano1(3).181029.1)
Abstract References License
78.10 10
3 Ceramic Hydroxyapatite Derived from Fish Scales in Biomedica… (10.33218/001c.120415)
References ORCID
38.91 5
4 Zebrafish (Danio rerio) as an ecotoxicological model for Nan… (10.33218/001c.21978)
References
38.91 35
5 Nanotechnology-Enhanced Controlled Release Systems in Topica… (10.33218/001c.127336)
References ORCID
34.95 4
6 Development of copper nanoparticles and their prospective us… (10.33218/001c.83932)
References
33.56 21
7 Lipid nanoparticle formulation of niclosamide (nano NCM) eff… (10.33218/001c.18813)
References
31.97 18
8 Origins to Outcomes: A Role for Extracellular Vesicles in Pr… (10.29016/180419.1)
References ORCID
30.10 3
9 Enhancing the Development of Therapeutics against SARS-CoV-2… (10.33218/001c.12680)
Abstract References ORCID License
30.10 1
10 A LIFESAVING WAKE-UP CALL FROM THE PAST: “WASH YOUR HANDS!” (10.33218/001c.12928)
Abstract References ORCID License
30.10 1
11 Launching stakeholder discussions on identified regulatory n… (10.33218/001c.13521)
References
30.10 15
12 Co-encapsulation by Flash NanoPrecipitation of Insulin, Tryp… (10.33218/001c.18519)
References ORCID
30.10 3
13 Lipid nanoparticle formulation of niclosamide (nano NCM) eff… (10.33218/001c.18814)
Abstract References ORCID License
30.10 1
14 Green Synthesized Nanoparticle Based Drug Delivery: Recent T… (10.33218/001c.89165)
References
30.10 15
15 Elevated circulating endothelin-1 as a potential biomarker f… (10.33218/001c.13525)
References
26.98 11
16 Nanorobotics in Medicine: A Systematic Review of Advances, C… (10.33218/001c.92224)
References
26.98 11
17 Advancements in Lipid Nanoparticle Technologies for Precisio… (10.33218/001c.121633)
References
25.00 9
18 Recent Advances in Nanocarrier Based Therapeutic and Diagnos… (10.33218/001c.90699)
References
25.00 9
19 Plant-Polyphenol-Mediated Synthesis of Magnetic Biocompatibl… (10.33218/001c.92424)
References
25.00 9
20 Nanotechnology-Powered Cosmetics: Progress in Hyperpigmentat… (10.33218/001c.131835)
References ORCID
23.86 2
21 Liposomal-Cannabidiol Injection; Preliminary Insights into P… (10.33218/001c.141764)
References ORCID
23.86 2
22 Pulmonary and intranasal delivery of thymoquinone-loaded nan… (10.33218/001c.24963)
References
23.86 8
23 Enhancing Sublingual Tablet Quality through QbD: Current Tre… (10.33218/001c.88223)
References
23.86 8
24 Mushroom-Derived Nanoparticles in Drug Delivery Systems – Th… (10.33218/001c.91083)
References
23.86 8
25 Nanotechnology to deliver cannabinoids in dermatology (10.33218/001c.24597)
References
22.58 7
26 Recent Advances of Nanocarriers for Effective Delivery of Th… (10.33218/001c.13444)
References
21.13 6
27 Enhancing the oral bioavailability of natural astaxanthin us… (10.33218/001c.16781)
References
19.45 5
28 Cellular uptake of nanoparticles: Involvement of caveolae? (10.33218/001c.22201)
References
19.45 5
29 Immunocompatibility of Rad-PC-Rad liposomes in vitro, based… (10.29016/180419.2)
References
17.47 4
30 The diagnostic potential of microneedles in infectious disea… (10.33218/001c.13658)
References
17.47 4
31 Personalized-dose Covid-19 vaccination in a wave of virus Va… (10.33218/001c.26101)
References
17.47 4
32 A Systematic Review of Cannabidiol Based Dosage Forms (10.33218/001c.30706)
References
17.47 4
33 Nanoliposomes as Drug Delivery Systems for Antifungal Therap… (10.33218/001c.56154)
References
17.47 4
34 The Application of Nanotechnology and Nanomaterials in Depre… (10.33218/001c.82215)
References
17.47 4
35 A Synergetic Approach Utilizing Nanotechnology, Chemotherapy… (10.33218/001c.90447)
References
17.47 4
36 Precision nanomedicine in atherosclerosis therapy: how far a… (10.33218/prnano2(1).181114.1)
ORCID
17.47 4
37 Precision COVID-19 Vaccine with Companion Diagnostics (10.33218/001c.12561)
References
15.05 3
38 Synthesis and Characterization of 5-Fluoroacil Loaded Calciu… (10.33218/001c.127799)
References ORCID
15.05 1
39 In vitro study of size-dependent inhibition of human cytochr… (10.33218/001c.129234)
References ORCID
15.05 1
40 Precision Medicine in Africa: Current State and Strategies f… (10.33218/001c.137477)
References ORCID
15.05 1
41 New Prospects for Therapeutic Organic Nanocrystals (10.33218/001c.146510)
References ORCID
15.05 1
42 Imaging the orientation of myelin sheaths in a non-stained h… (10.33218/001c.17211)
References
15.05 3
43 Perillyl Alcohol in Solid Lipid Nanoparticles (SLN-PA): Cyto… (10.33218/001c.17880)
References
15.05 3
44 Rethinking Our COVID-19 Strategy (10.33218/001c.21569)
References ORCID
15.05 1
45 Science, Pseudo-science, False, and Fake “science”. Why is t… (10.33218/001c.34241)
References
15.05 3
46 Engineered superparamagnetic iron oxide nanoparticles for ex… (10.33218/001c.37603)
References
15.05 3
47 Injectable nanogel systems for brain drug delivery (10.33218/001c.88217)
References
15.05 3
48 Effectiveness of Lecanemab on Alzheimer’s Disease (10.33218/001c.92098)
References ORCID
15.05 1
49 Specific Molecular Recognition as a Strategy to Delineate Tu… (10.33218/prnano1(3).181009.1)
ORCID
15.05 3
50 Paranoid Schizophrenia Diagnosis via Complex Network Analysi… (10.33218/001c.128586)
References
11.93 2